AU1037699A - Method for diagnosing in vitro pathologies associated with gene arrangements anddiagnosis kits - Google Patents

Method for diagnosing in vitro pathologies associated with gene arrangements anddiagnosis kits

Info

Publication number
AU1037699A
AU1037699A AU10376/99A AU1037699A AU1037699A AU 1037699 A AU1037699 A AU 1037699A AU 10376/99 A AU10376/99 A AU 10376/99A AU 1037699 A AU1037699 A AU 1037699A AU 1037699 A AU1037699 A AU 1037699A
Authority
AU
Australia
Prior art keywords
diagnosing
vitro
anddiagnosis
kits
pathologies associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10376/99A
Inventor
Jean Gabert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1037699A publication Critical patent/AU1037699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)

Abstract

The invention concerns a method for diagnosing in vitro pathologies associated with gene arrangements which consists in subjecting the DNA under study to at least a step of asymmetric amplification with a single pair of primers and in only revealing the gene capable of being involved in gene fusion insofar as the fusion exists. The invention is applicable to the diagnosis of leukaemia.
AU10376/99A 1997-10-30 1998-10-29 Method for diagnosing in vitro pathologies associated with gene arrangements anddiagnosis kits Abandoned AU1037699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9713656 1997-10-30
FR9713656A FR2770539B1 (en) 1997-10-30 1997-10-30 METHOD OF IN VITRO DIAGNOSIS OF PATHOLOLGIA ASSOCIATED WITH GENE SHIFT AND DIAGNOSTIC KITS
PCT/FR1998/002320 WO1999023251A1 (en) 1997-10-30 1998-10-29 Method for diagnosing in vitro pathologies associated with gene arrangements and diagnosis kits

Publications (1)

Publication Number Publication Date
AU1037699A true AU1037699A (en) 1999-05-24

Family

ID=9512854

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10376/99A Abandoned AU1037699A (en) 1997-10-30 1998-10-29 Method for diagnosing in vitro pathologies associated with gene arrangements anddiagnosis kits

Country Status (7)

Country Link
EP (1) EP1025264B1 (en)
AT (1) ATE356883T1 (en)
AU (1) AU1037699A (en)
CA (1) CA2308019A1 (en)
DE (1) DE69837344D1 (en)
FR (1) FR2770539B1 (en)
WO (1) WO1999023251A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2494069B1 (en) * 2009-10-30 2013-10-02 Roche Diagniostics GmbH Method for detecting balanced chromosomal aberrations in a genome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024934A (en) * 1988-03-14 1991-06-18 The Board Of Regents, The University Of Texas System Detection of minimal numbers of neoplastic cells carrying DNA translocations by DNA sequence amplification
WO1993025713A1 (en) * 1992-06-17 1993-12-23 Arch Development Corporation Compositions and methods for detecting gene rearrangements and translocations
AU4681693A (en) * 1992-07-17 1994-02-14 Aprogenex, Inc. Nucleic acid probes and uses thereof to detect double-stranded nucleic acids
US6080851A (en) * 1992-12-04 2000-06-27 American Home Products Corporation Ribozymes with linked anchor sequences
US5985598A (en) * 1994-10-27 1999-11-16 Thomas Jefferson University TCL-1 gene and protein and related methods and compositions

Also Published As

Publication number Publication date
FR2770539B1 (en) 2001-07-27
ATE356883T1 (en) 2007-04-15
EP1025264B1 (en) 2007-03-14
FR2770539A1 (en) 1999-05-07
CA2308019A1 (en) 1999-05-14
DE69837344D1 (en) 2007-04-26
WO1999023251A1 (en) 1999-05-14
EP1025264A1 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
AU772812C (en) Alzheimer's disease secretase
AU7222698A (en) Method of preparing a standard diagnostic gene transcript pattern
WO2000028090A3 (en) Diagnostic assay for cancer
MXPA02006145A (en) Method for isolation of rna from formalinfixed paraffinembedded tissue specimens.
AU2002348563A1 (en) Nucleic acid enrichment
BG101103A (en) Mammalian telomerase
EA199700355A1 (en) METHOD OF DIAGNOSTIC SCHIZOPHRENIA
WO2000069896A3 (en) Molecular interactions in haematopoietic cells
CA2298681A1 (en) Methods and compositions for overcoming resistance to biologic and chemotherapy
WO2000034525A8 (en) Toxicity typing using embryoid bodies
EP1102988B8 (en) Method of determining the immune response activity of blood and test kit therefor
WO2002042422A3 (en) Molecular interactions in hematopoietic cells
GB2388190B (en) Methods for measuring enzyme activity
WO2002088387A3 (en) Amplification process
EP1163515A4 (en) Therapeutic and diagnostic tools for impaired glucose tolerance conditions
AU2002303437A1 (en) Isolation of neural stem cells using gangliosides and other surface markers
RS20100249A (en) Conjugates and methods for the production thereof and their use for transporting molecules via biological membranes
EP1179183A4 (en) A method for identifying pre-neoplastic and/or neoplastic states in mammals
AU1037699A (en) Method for diagnosing in vitro pathologies associated with gene arrangements anddiagnosis kits
MXPA02010868A (en) Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate.
WO2000034504A3 (en) Method of protein removal
AU2676801A (en) Xylosyltransferase and isoforms thereof
WO2002062970A8 (en) Enteric nervous system derived stem and progenitor cells and uses thereof
GT200000138CA (en) GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138)
WO2002031512A3 (en) Molecular interactions in hematopoietic cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase